Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

Trial Profile

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Florbetapir F 18 (Primary)
  • Indications Alzheimer's disease; Cognition disorders
  • Focus Diagnostic use
  • Acronyms RAmP
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 01 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 28 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 04 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top